Ambenonium resources

DRUG INFO
Ambenonium

Drug Name: Ambenonium


Indication: Ambenonium is used to treat muscle weakness due to muscle disease (myasthenia gravis).



Pharmacology: Ambenonium, similar to pyridostigmine and neostigmine, is used for the treatment of muscle weakness and fatigue in people with myasthenia gravis. It is postulated to exert its therapeutic effect by enhancing cholinergic function by inhibiting the hydrolysis of acetylcholine by acetylcholinesterase. Increased levels of acetylcholine has peripheral effects, as acetylcholine is also used in the brain, where it tends to cause excitatory actions. The glands that receive impulses from the parasympathetic part of the autonomic nervous system are also stimulated in the same way. This is why an increase in acetylcholine causes a decreased heart rate and increased production of saliva. Ambenonium is used less commonly than neostigmine or pyridostigmine but may be preferred in patients hypersensitive to the bromide ion. Ambenonium produces fewer muscarinic side effects than neostigmine, but more than pyridostigmine.

Mechanism Of Action: Ambenonium exerts its actions against myasthenia gravis by competitive, reversible inhibition of acetylcholinesterase. The disease myasthenia gravis occurs when the body inappropriately produces antibodies against acetylcholine receptors, and thus inhibits proper acetylcholine signal transmission (when acetylcholine binds to acetylcholine receptors of striated muscle fibers, it stimulates those fibers to contract). Ambenonium reversibly binds acetylcholinesterase, and as acetylcholinesterase is responsible for the hydrolysis of acetylcholine, this inhibition increases levels of acetylcholine. In turn this facilitates transmission of impulses across the myoneural junction and effectively treats the disease.

Drug Category: Antiarrhythmic Agents; Antimyasthenics; ATC:N07AA30

Brand Names/Synonyms: Ambenonium; Ambenonium Base; Ambenonium Kation; Ambenonium [Usan]; Ambenonum; CHEMBANK2927; Mytelase

Dosage Forms: TABLET (10 mg)

Absorption: Oral - poorly absorbed from the gastrointestinal tract.

Interactions: DrugBank: Interactions for Ambenonium

Interactions for Ambenonium:


Interactions can occur with the following medications: demecarium (Humorsol), echothiophate (Phospholine Iodide), isoflurophate (Floropryl), malathion (using these medicines with antimyasthenics may result in serious side effects), guanadrel (Hylorel), guanethidine (Ismelin), mecamylamine (Inversine), procainamide (Pronestyl), and trimethaphan (the effects of these medicines may interfere with the actions of the antimyasthenics).



Chemical IUPAC Name: (2-chlorophenyl)methyl-[2-[2-[(2-chlorophenyl)methyl-diethyl-ammonio]ethylcarbamoylformyl]aminoethyl]-diethyl-ammonium

Chemical Formula: C28H42Cl2N4O2

Half Life: Not Available

Drug Type: Approved Drug

# Accession No: APRD00771

CAS Registry Number: 7648-98-8